Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- CBAV.MC
- Price
- 31.20
- Stock movement up
- +- (%)
- Company name
- Clinica Baviera
- Exchange
- (MC ,
- Currency
- EUR )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 498.78M
- Ent value
- 584.14M
- Price/Sales
- 1.98
- Price/Book
- 5.86
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 0.09%
- Trailing P/E
- 13.45
- Forward P/E
- -
- PEG
- -
- EPS growth
- 24.92%
- 1 year return
- 35.65%
- 3 year return
- 9.44%
- 5 year return
- 17.89%
- 10 year return
- 11.14%
Last updated: 2025-01-02
DIVIDENDS
CBAV.MC does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 13.45 |
| Price to OCF | 7.91 |
| Price to FCF | 13.71 |
| Price to EBITDA | 7.00 |
| EV to EBITDA | 8.20 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 1.98 |
| Price to Book | 5.86 |
| EV to Sales | 2.32 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 15.99M |
| EPS (TTM) | 2.01 |
| FCF per share (TTM) | 1.97 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 251.69M |
| Gross profit (TTM) | 169.55M |
| Operating income (TTM) | 46.48M |
| Net income (TTM) | 37.07M |
| EPS (TTM) | 2.01 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 67.37% |
| Operating margin (TTM) | 18.47% |
| Profit margin (TTM) | 14.73% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 32.28M |
| Net receivables | 0.00 |
| Total current assets | 41.27M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 202.74M |
| Accounts payable | 20.46M |
| Short/Current long term debt | 61.52M |
| Total current liabilities | 51.70M |
| Total liabilities | 117.63M |
| Shareholder's equity | 85.10M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 63.04M |
| Capital expenditures (TTM) | 26.67M |
| Free cash flow (TTM) | 36.37M |
| Dividends paid (TTM) | 33.52K |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 43.56% |
| Return on Assets | 18.29% |
| Return on Invested Capital | 43.56% |
| Cash Return on Invested Capital | 42.74% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 32.00 |
| Daily high | 32.00 |
| Daily low | 31.20 |
| Daily Volume | 0K |
| All-time high | 38.80 |
| 1y analyst estimate | 24.30 |
| Beta | 0.68 |
| EPS (TTM) | 2.01 |
| Dividend per share | - |
| Ex-div date | 16 Jul 2024 |
| Next earnings date | 26 Feb 2025 |
Downside potential
Loading...
Downside potential data
| CBAV.MC | S&P500 | |
| Current price drop from All-time high | -19.59% | -3.58% |
| Highest price drop | -86.00% | -56.47% |
| Date of highest drop | 5 Dec 2012 | 9 Mar 2009 |
| Avg drop from high | -53.43% | -11.12% |
| Avg time to new high | 134 days | 12 days |
| Max time to new high | 3941 days | 1805 days |
COMPANY DETAILS
Marketcap
498.78M
Marketcap category
Small-cap
Description
Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments. The company is based in Madrid, Spain.
Employees
1326
Investor relations
-
SEC filings
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As global markets navigate a period of mixed economic signals, with the Nasdaq reaching new heights amid broader index declines and central banks adjusting interest rates, investors are increasingly f...
December 19, 2024
In the wake of a significant rally in U.S. stocks following the election, with small-cap indices like the Russell 2000 showing notable gains, investors are increasingly optimistic about economic growt...
November 15, 2024
As global markets react to recent political shifts and economic policy changes, U.S. stocks have rallied to record highs, buoyed by expectations of growth-friendly policies and tax reforms. In this dy...
November 11, 2024
As global markets experience a mix of highs and lows, with U.S. indices reaching record levels amid the onset of earnings season, investors are navigating a landscape marked by modest inflation surpri...
October 18, 2024
As global markets rebound from recent sell-offs and central banks adjust interest rates, investors are keenly observing opportunities for stable returns amidst economic shifts. With core inflation sli...
September 19, 2024